Most cited papers from Carmel Medical Center

Carmel Medical Center

What are the most cited papers from Carmel Medical Center?

The most cited paper from Carmel Medical Center is "Dabigatran versus Warfarin in Patients with Atrial Fibrillation" (Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al., 2009), with 11,272 citations. Next come "Apixaban versus Warfarin in Patients with Atrial Fibrillation" (9,001) and "Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials" (5,070).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 394 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Dabigatran versus Warfarin in Patients with Atrial Fibrillation Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf et al. · New England Journal of Medicine Open access	30 Aug 2009	11,272
2	Apixaban versus Warfarin in Patients with Atrial Fibrillation Christopher B. Granger et al. · New England Journal of Medicine Open access	28 Aug 2011	9,001
3	Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials Christian Thomas Ruff, Robert Patrick Giugliano, Eugene Braunwald et al. · The Lancet Review	4 Dec 2013	5,070
4	Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes Christopher P. Cannon et al. · New England Journal of Medicine Open access	4 Jun 2015	4,523
5	Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study Shamir R. Mehta, Salim Yusuf, Ron J.G. Peters et al. · The Lancet	Aug 2001	2,820
6	Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease John W. Eikelboom et al. · New England Journal of Medicine Open access	27 Aug 2017	2,456
7	Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial Sanjit S. Jolly, Salim Yusuf, John A. Cairns et al. · The Lancet	Apr 2011	2,130
8	Association analysis identifies 65 new breast cancer risk loci Kyriaki Michailidou et al. · Nature Open access362 authors	20 Oct 2017	1,602
9	Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes Nasim Mavaddat et al. · The American Journal of Human Genetics Open access269 authors	13 Dec 2018	1,213
10	SCCT guidelines for the performance and acquisition of coronary computed tomographic angiography: A report of the Society of Cardiovascular Computed Tomography Guidelines Committee Suhny Abbara, Philipp Blanke, Christopher D. Maroules et al. · Journal of cardiovascular computed tomography	16 Oct 2016	1,109
11	Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial Sonia S. Anand et al. · The Lancet Open access644 authors	10 Nov 2017	892
12	Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease Salim Yusuf et al. · New England Journal of Medicine Open access	2 Apr 2016	854
13	Statins and the Risk of Colorectal Cancer Jenny N. Poynter, Stephen B. Gruber, Peter Higgins et al. · New England Journal of Medicine	25 May 2005	831
14	Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes James McKay et al. · Nature Genetics Open access140 authors	12 Jun 2017	808
15	Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial Piotr P. Ponikowski et al. · The Lancet Open access210 authors	13 Nov 2020	797
16	Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease Marc P. Bonaca, Patrice Nault, Robert Patrick Giugliano et al. · Circulation Open access	13 Nov 2017	768
17	Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes Pierluigi Tricoci et al. · New England Journal of Medicine Open access	13 Nov 2011	757
18	Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis Nikos Papadimitriou et al. · Nature Communications Open access	30 Jan 2020	714
19	Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis Manish Motwani et al. · European Heart Journal Open access	Jun 2016	709
20	Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1 Gemma L. Carvill et al. · Nature Genetics Open access	26 May 2013	707
21	Effects of Aspirin Dose When Used Alone or in Combination With Clopidogrel in Patients With Acute Coronary Syndromes Ron J.G. Peters, Shamir R. Mehta, Keith A.A. Fox et al. · Circulation Open access	22 Sep 2003	704
22	Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study Victoria Furer et al. · Annals of the Rheumatic Diseases Open access	14 Jun 2021	697
23	Pulmonary Hypertension in Chronic Lung Diseases Werner Seeger, Yochai Adir, Joan Albert Barberà et al. · Journal of the American College of Cardiology Open access	Dec 2013	685
24	Cystic fibrosis Michal Shteinberg, Iram J. Haq, Deepika Polineni et al. · The Lancet	Jun 2021	680
25	Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4–5 chronic kidney disease (the C-SURFER study): a combination phase 3 study David Roth, David R. Nelson, Annette N. Bruchfeld et al. · The Lancet Open access	Oct 2015	673
26	Are Hospitalized or Ambulatory Patients with Heart Failure Treated in Accordance with European Society of Cardiology Guidelines? Evidence from 12 440 Patients of the ESC Heart Failure Long-Term Registry Aldo Pietro Maggioni et al. · European Journal of Heart Failure Open access	26 Aug 2013	672
27	Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study Robert Carreras‐Torres et al. · PLoS ONE Open access	8 Jun 2017	668
28	Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study Christopher Paul Cannon, Robert A. Harrington, Stefan Karl James et al. · The Lancet	2010	664
29	Pulmonary Hypertension Due to Left Heart Diseases Jean-Luc Vachiéry, Yochai Adir, Joan Albert Barberà et al. · Journal of the American College of Cardiology Open access	Dec 2013	637
30	Network modeling links breast cancer susceptibility and centrosome dysfunction Miguel Ángel Pujana et al. · Nature Genetics	7 Oct 2007	636
31	Blood-Pressure Lowering in Intermediate-Risk Persons without Cardiovascular Disease Eva Lonn et al. · New England Journal of Medicine Open access	2 Apr 2016	622
32	Clinical Practice Update on Heart Failure 2019: Pharmacotherapy, Procedures, Devices and Patient Management. An Expert Consensus Meeting Report of the Heart Failure Association of the European Society of Cardiology Petar M Seferovic et al. · European Journal of Heart Failure Open access	26 May 2019	615
33	Discovery of common and rare genetic risk variants for colorectal cancer Jeroen R. Huyghe et al. · Nature Genetics Open access199 authors	26 Nov 2018	611
34	Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21 Albert Tenesa et al. · Nature Genetics Open access	30 Mar 2008	606
35	Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial Marc Steven Sabatine, Lawrence A. Leiter, Stephen D. Wiviott et al. · The Lancet Diabetes & Endocrinology Open access	15 Sep 2017	604
36	Brain and Neck Tumors Among Physicians Performing Interventional Procedures Ariel Roguin, Jacob Goldstein, Olivier Bar et al. · The American Journal of Cardiology	16 Feb 2013	592
37	Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses Haoyu Zhang et al. · Nature Genetics Open access276 authors	18 May 2020	587
38	Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer Catherine M. Phelan et al. · Nature Genetics Open access420 authors	27 Mar 2017	566
39	The earliest modern humans outside Africa Israël Hershkovitz et al. · Science	25 Jan 2018	554
40	Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients Ronza Najjar‐Debbiny, Naomi Gronich, Regina Weber et al. · Clinical Infectious Diseases Open access	2 Jun 2022	548
41	Dronedarone in High-Risk Permanent Atrial Fibrillation Stuart J. Connolly et al. · New England Journal of Medicine Open access	14 Nov 2011	544
42	36th International Symposium on Intensive Care and Emergency Medicine R. M. Bateman et al. · Critical Care Open access2,440 authors	Apr 2016	531
43	Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes Robert Patrick Giugliano, Jennifer A. White, Christoph Bode et al. · New England Journal of Medicine Open access	31 Mar 2009	514
44	Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules Morad K. Nakhleh et al. · ACS Nano Open access	21 Dec 2016	507
45	Gentamicin-Induced Correction of CFTR Function in Patients with Cystic Fibrosis and CFTR Stop Mutations Michael A. Wilschanski, Yaacov Yahav, Yasmin Yaacov et al. · New England Journal of Medicine Open access	8 Oct 2003	499
46	Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin Paul Moayyedi et al. · Gastroenterology Open access	29 May 2019	484
47	Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer ABCTB Investigators et al. · Nature Genetics Open access476 authors	23 Oct 2017	477
48	Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease Aaron Lerner, Torsten Matthias · Autoimmunity Reviews Open access	9 Feb 2015	469
49	Genetic insights into biological mechanisms governing human ovarian ageing Katherine S. Ruth et al. · Nature Open access274 authors	4 Aug 2021	468
50	Risk of Infection and Death Among Post-splenectomy Patients Naiel Bisharat, Hussam Omari, I. Lavi et al. · Journal of Infection	Oct 2001	468

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.